Sponsor
Biotherapeutics for Cancer Treatment
Description
Founded in 2015, BioCanRx (Biotherapeutics for Cancer Treatment) is a not-for-profit organization with a mission to improve outcomes for cancer patients by accelerating the development of cost-effective and curative biotherapies. BioCanRx was awarded seed funding of $25 million from the federal government’s Networks of Centres of Excellence (NCE) Program, and has attracted additional tens of millions from partners in all sectors of the economy.
BioCanRx supports biotherapeutic development research through four research programs and a number of core facilities that are accessible to all members of the BioCanRx network. Three of the research programs (Catalyst Projects, Enabling Studies, Clinical Trials) are designed to reflect the translational focus of BioCanRx, which organizes its investments into a pipeline-like structure common to the biotechnology industry. The fourth program (Clinical, Social, and Economic Impact Program) funds research into issues of scientific methodology, clinical trial design, patient engagement, health economics and commercial viability of BioCanRx biotherapeutic platforms and technologies. All research programs are targeted toward applicants who have already made substantial advances in their basic research programs and are now ready to work in collaborative, multidisciplinary, academic–industry teams to move their discoveries into the clinic in a rational, scientifically well-supported and highly disciplined fashion.
Eligibility
All investigators located at Canadian institutions eligible to receive peer-reviewed funding from the three federal research-granting councils (CIHR, SSHRC, NSERC).
Funding Availability
BioCanRx was awarded seed funding of $25 million from the federal government’s Networks of Centres of Excellence (NCE) Program, and has attracted additional tens of millions from partners in all sectors of the economy.
Indirect Costs
0%
Special Notes
BioCanRx uses a rolling open call that starts with a letter-of-intent stage and has submission deadlines that are structured around the meeting dates of our Research Management Committee.
Deadlines
If College-level review is required, your College will communicate its earlier internal deadlines.
| Type | Notes |
|---|---|
Internal Deadline | One week prior to submission of application (if invited) to sponsor, send an OR-5 form along with a copy of application to research.services@uoguelph.ca.
|
External Deadline | Rolling call Recommended process:
More information can be found at BioCanRX. |
How to Apply
The completed letter of intent (LOI) application must be delivered by email to applications@biocanrx.com.
If invited, the application package must be delivered by email to applications@biocanrx.com.
Information For Co-applicants
If you need to meet a deadline set by the lead institution for this opportunity, please ensure that you provide the Office of Research with at least five days in advance of the lead institution’s deadline to review the application, or your proposed component of the project. Please be in touch with the Office of Research (contact information below) ahead of the deadline if it looks like it will be difficult for you to submit all the required documentation on time (i.e. budget, proposal, OR-5 Form).